Citigroup Inc. boosted its stake in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 94.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 151,520 shares of the company’s stock after acquiring an additional 73,457 shares during the quarter. Citigroup Inc.’s holdings in Perrigo were worth $3,974,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Foundry Partners LLC bought a new position in shares of Perrigo in the 3rd quarter valued at about $7,111,000. AQR Capital Management LLC raised its holdings in Perrigo by 675.5% during the 2nd quarter. AQR Capital Management LLC now owns 970,637 shares of the company’s stock worth $24,926,000 after buying an additional 845,470 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in Perrigo by 3.8% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 655,974 shares of the company’s stock worth $16,845,000 after buying an additional 23,835 shares during the period. Victory Capital Management Inc. raised its holdings in Perrigo by 23.2% during the 2nd quarter. Victory Capital Management Inc. now owns 1,405,553 shares of the company’s stock worth $36,095,000 after buying an additional 264,647 shares during the period. Finally, O Keefe Stevens Advisory Inc. raised its holdings in shares of Perrigo by 36.8% in the third quarter. O Keefe Stevens Advisory Inc. now owns 182,516 shares of the company’s stock valued at $4,787,000 after purchasing an additional 49,075 shares during the last quarter. Institutional investors own 95.91% of the company’s stock.
Insider Transactions at Perrigo
In related news, Director Katherine C. Doyle sold 8,954 shares of the stock in a transaction on Friday, September 13th. The stock was sold at an average price of $27.30, for a total value of $244,444.20. Following the completion of the sale, the director now directly owns 6,009 shares of the company’s stock, valued at approximately $164,045.70. This represents a 59.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.40% of the stock is owned by insiders.
Analysts Set New Price Targets
Read Our Latest Research Report on PRGO
Perrigo Stock Performance
NYSE:PRGO opened at $28.42 on Wednesday. The stock’s 50-day moving average is $26.09 and its 200-day moving average is $27.00. Perrigo Company plc has a 1-year low of $23.89 and a 1-year high of $34.60. The stock has a market cap of $3.88 billion, a P/E ratio of -24.29 and a beta of 0.52. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94.
Perrigo (NYSE:PRGO – Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.81 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.81. The firm had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.12 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The company’s revenue for the quarter was down 3.2% compared to the same quarter last year. During the same period in the prior year, the business earned $0.64 EPS. Equities research analysts anticipate that Perrigo Company plc will post 2.56 earnings per share for the current year.
Perrigo Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Friday, November 29th will be given a dividend of $0.276 per share. This represents a $1.10 dividend on an annualized basis and a dividend yield of 3.88%. The ex-dividend date of this dividend is Friday, November 29th. Perrigo’s payout ratio is -94.02%.
Perrigo Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Articles
- Five stocks we like better than Perrigo
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Stock Analyst Ratings and Canadian Analyst Ratings
- Netflix Is On Track To Hit $1,000 By Christmas
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.